# Reducing Lung Cancer-Related Anxiety (RELAX)

> **NCT02063828** · NA · TERMINATED · sponsor: **Wake Forest University Health Sciences** · enrollment: 46 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **DEVICE:** Group A - Device guided breathing low dose
- **DEVICE:** Group B - Device guided breathing high dose
- **DEVICE:** Group C - Usual Breathing Control Group

## Key facts

- **NCT ID:** NCT02063828
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-07-30
- **Primary completion:** 2019-12-23
- **Final completion:** 2019-12-23
- **Target enrollment:** 46 (ACTUAL)
- **Why stopped:** Took too long to accrue participants, stopped for feasibility concerns
- **Last updated:** 2021-03-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02063828

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02063828, "Reducing Lung Cancer-Related Anxiety (RELAX)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02063828. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*